Acutaas Chemicals, formerly Ami Organics, reported a stellar FY26 with a 33% revenue growth and a 122% surge in net profit. The company successfully expanded into high-growth battery and semiconductor chemical sectors, backed by long-term contracts. Margins improved significantly as the company diversified beyond pharmaceuticals. The board also recommended a dividend of Rs 2.50 per share.
Acutaas Chemicals FY26 Profit Hits Rs 3,564 Million
Revenue grew by 33% to Rs 13,394 million, while EBITDA margins expanded by 1,290 bps to 35.9%.
Reader Takeaway: Strong margin expansion and new segment diversification provide growth, but execution risk in semiconductor chemicals remains key.
What just happened
Acutaas Chemicals Limited has released its FY26 Annual Report, marking a transformative year following its rebranding from Ami Organics. The company delivered a robust performance with PAT surging 122% to Rs 3,564 million. Operational highlights include the successful completion of the Phase I battery chemicals project in Jhagadia and progress in the semiconductor chemicals space via its South Korean joint venture, Indichem Inc.
Why this matters
The company has effectively reduced its reliance on the pharmaceutical sector by scaling its specialty chemicals division, which grew from 1% of revenue in FY19 to 12% in FY26. The battery chemicals segment is particularly de-risked by three-year long-term customer contracts, providing stable revenue visibility. The board's recommendation of a Rs 2.50 per share dividend reflects strong cash flows.
Strategic Developments
Capex remains disciplined, with Rs 1,950 million deployed specifically toward projects with visible or contracted demand. The company is seeking shareholder approval for material related party transactions with its subsidiary, Acutaas Chemicals Electrolytes Private Limited, valued at Rs 2,900 million, to support internal expansion.
Risks to watch
Investors should monitor the timeline for the South Korean semiconductor manufacturing facility, which is currently under construction. While the battery chemicals capacity is contracted, sustained demand in the highly competitive semiconductor chemical ecosystem will be a critical monitorable for long-term growth.
Context metrics
- EBITDA: Rs 4,804 million (vs Rs 2,321 million in FY25)
- EBITDA Margin: 35.9% (up from 23.0% YoY)
- Dividend: Rs 2.50 per share